EBITDA: Income before interest, taxes, depreciation and amortization.
Bluejay Diagnostics, Inc. (BJDX) had EBITDA of $-1.84M for the most recently reported fiscal quarter, ending 2024-06-30.
| Income Statement Financials | |
-- |
|
$-2.48M |
|
-- |
|
-- |
|
$1.90M |
|
$-1.90M |
|
$-0.58M |
|
$-2.48M |
|
$-2.48M |
|
$-2.48M |
|
$-2.48M |
|
$-2.48M |
|
$-2.48M |
|
$-1.90M |
|
|
EBITDA |
$-1.84M |
0.48M |
|
0.48M |
|
$-5.12 |
|
$-5.12 |
|
| Balance Sheet Financials | |
$9.02M |
|
$1.55M |
|
$1.84M |
|
$10.86M |
|
$2.06M |
|
-- |
|
$0.16M |
|
$2.22M |
|
$8.64M |
|
$8.64M |
|
$8.64M |
|
2.58M |
|
| Cash Flow Statement Financials | |
$-4.15M |
|
$-0.31M |
|
$10.30M |
|
$2.21M |
|
$8.06M |
|
$5.85M |
|
$0.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.38 |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.46M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-28.65% |
|
-28.65% |
|
-22.80% |
|
-28.65% |
|
$3.34 |
|
$-9.22 |
|
$-8.59 |
|